Answers are grounded in this paper and cite their sources.
This work highlights the transcriptional action of LXR as a protective pathway in brain injury and the potential use of LXR agonists as therapeutic agents in stroke.
No takes yet. Share an insight, caveat, or question.
Morales et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: